http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004191802-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2003-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbf46922b99320f9327ea2388dd49140 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_463ae433ff713c4211eece412527a042 |
| publicationDate | 2004-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2004191802-A1 |
| titleOfInvention | Phospholamban polymorphism and methods of assessment |
| abstract | Methods of phospholamban mutation/polymorphism assessment in an individual comprise the steps of obtaining a sample from an individual; isolating a nucleotide fragment containing a phospholamban coding region from the sample; analyzing the nucleotide fragment; and comparing the analysis of the nucleotide fragment with a predetermined phospholamban nucleotide fragment sequence to determine whether the individual carries a phospholamban polymorphism. An isolated phospholamban mutation/polymorphism fragment comprises SEQ ID NO:1. Methods for determining if an individual is at risk for developing a cardiovascular disease are also provided. |
| priorityDate | 2002-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.